The emergence of nitroxyl (HNO) as
a biological signaling molecule
is attracting increasing attention. HNO-based prodrugs show considerable
potential in treating congestive heart failure, with HNO reacting
rapidly with metal centers and protein-bound and free thiols. A new
class of 2-(2-nitrophenyl)ethyl (2-NPE)-photocaged N-hydroxysulfonamides has been developed, and the mechanisms of photodecomposition
have been investigated. Three photodecomposition pathways are observed:
the desired concomitant C–O/N–S bond cleavage to generate
HNO, sulfinate, and 2-nitrostyrene, C–O bond cleavage to give
the parent sulfohydroxamic acid and 2-nitrostyrene, and O–N
bond cleavage to release a sulfonamide and 2-nitrophenylacetaldehyde.
Laser flash photolysis experiments provide support for a Norrish type
II mechanism involving 1,5-hydrogen atom abstraction to generate an aci-nitro species. A mechanism is proposed in which the
(Z)-aci-nitro intermediate undergoes
either C–O bond cleavage to release RSO2NHO(H),
concerted C–O/N–S bond cleavage to generate sulfinate
and HNO, or isomerization to the (E)-isomer prior
to O–N bond cleavage. The pK
a of
the N(H) of the N-hydroxysulfonamide plays a key
role in determining whether C–O or concerted C–O/N–S
bond cleavage occurs. Deprotonating this site favors the desired C–O/N–S
bond cleavage at the expense of an increased level of undesired O–N
bond cleavage. Triplet state quenchers have no effect on the observed
photoproducts.